Legal & General Group Plc Increases Stock Position in Indivior PLC (NASDAQ:INDV)

Legal & General Group Plc boosted its position in shares of Indivior PLC (NASDAQ:INDV) by 1.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 715,920 shares of the company’s stock after acquiring an additional 9,978 shares during the period. Legal & General Group Plc’s holdings in Indivior were worth $9,181,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Stifel Financial Corp acquired a new stake in shares of Indivior during the 3rd quarter valued at about $100,000. Jane Street Group LLC acquired a new stake in Indivior in the third quarter valued at approximately $180,000. Public Employees Retirement System of Ohio purchased a new stake in shares of Indivior in the third quarter valued at approximately $294,000. Geode Capital Management LLC raised its stake in shares of Indivior by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 132,239 shares of the company’s stock worth $1,289,000 after buying an additional 9,500 shares during the period. Finally, Hennion & Walsh Asset Management Inc. purchased a new position in shares of Indivior during the 4th quarter valued at approximately $1,192,000. Hedge funds and other institutional investors own 60.33% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on INDV. RODMAN&RENSHAW upgraded shares of Indivior to a “strong-buy” rating in a research report on Tuesday, January 28th. Rodman & Renshaw initiated coverage on shares of Indivior in a research report on Tuesday, January 28th. They set a “buy” rating and a $16.00 price target for the company. Finally, Piper Sandler lowered their price objective on Indivior from $16.00 to $13.00 and set an “overweight” rating on the stock in a report on Thursday, March 6th.

Indivior Stock Down 0.6 %

Shares of INDV opened at $9.01 on Friday. Indivior PLC has a 52-week low of $7.33 and a 52-week high of $19.13. The stock has a market cap of $1.24 billion, a PE ratio of -25.74 and a beta of 0.93. The firm’s fifty day moving average is $9.52 and its two-hundred day moving average is $10.33.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.32 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.32. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The firm had revenue of $298.00 million for the quarter, compared to analyst estimates of $262.35 million. As a group, research analysts anticipate that Indivior PLC will post 1.22 earnings per share for the current year.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.